vs
BillionToOne, Inc.（BLLN）与GDEV Inc.（GDEV）财务数据对比。点击上方公司名可切换其他公司
GDEV Inc.的季度营收约是BillionToOne, Inc.的1.4倍（$119.9M vs $83.5M），GDEV Inc.净利率更高（13.9% vs 6.8%，领先7.0%），BillionToOne, Inc.同比增速更快（117.4% vs 13.3%）
BillionToOne, Inc.是一家生命科学与分子诊断企业，专注研发高精度基因检测解决方案，核心产品包括无创产前检测、肿瘤诊断试剂及罕见病筛查服务，服务全球多地的医疗机构、患者及科研合作方。
GDEV Inc.是一家游戏娱乐控股公司，在纳斯达克上市，总部位于塞浦路斯利马索尔。该公司前身为2014年成立的游戏公司Nexters，2023年6月改组为控股集团，是欧洲前五的独立移动游戏企业，旗下拥有Nexters Studio、Cubic Games、Royal Ark、Game Gears、Light Hour Games等工作室，分支机构分布在塞浦路斯、亚美尼亚、哈萨克斯坦等地。
BLLN vs GDEV — 直观对比
营收规模更大
GDEV
是对方的1.4倍
$83.5M
营收增速更快
BLLN
高出104.1%
13.3%
净利率更高
GDEV
高出7.0%
6.8%
损益表 — Q3 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.5M | $119.9M |
| 净利润 | $5.7M | $16.6M |
| 毛利率 | 69.9% | — |
| 营业利润率 | 11.5% | 15.5% |
| 净利率 | 6.8% | 13.9% |
| 营收同比 | 117.4% | 13.3% |
| 净利润同比 | 138.3% | 13.0% |
| 每股收益（稀释后） | $0.10 | $0.90 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLLNGDEV
| Q3 25 | $83.5M | — | ||
| Q2 25 | — | $119.9M | ||
| Q4 24 | $45.1M | — | ||
| Q3 24 | $38.4M | — | ||
| Q2 24 | — | $105.8M | ||
| Q2 23 | — | $114.9M | ||
| Q2 22 | — | $125.8M |
净利润BLLNGDEV
| Q3 25 | $5.7M | — | ||
| Q2 25 | — | $16.6M | ||
| Q4 24 | $-11.5M | — | ||
| Q3 24 | $-14.9M | — | ||
| Q2 24 | — | $14.7M | ||
| Q2 23 | — | $19.5M | ||
| Q2 22 | — | $29.3M |
毛利率BLLNGDEV
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
营业利润率BLLNGDEV
| Q3 25 | 11.5% | — | ||
| Q2 25 | — | 15.5% | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | -32.9% | — | ||
| Q2 24 | — | 14.4% | ||
| Q2 23 | — | 12.9% | ||
| Q2 22 | — | 34.4% |
净利率BLLNGDEV
| Q3 25 | 6.8% | — | ||
| Q2 25 | — | 13.9% | ||
| Q4 24 | -25.5% | — | ||
| Q3 24 | -38.8% | — | ||
| Q2 24 | — | 13.9% | ||
| Q2 23 | — | 17.0% | ||
| Q2 22 | — | 23.3% |
每股收益（稀释后）BLLNGDEV
| Q3 25 | $0.10 | — | ||
| Q2 25 | — | $0.90 | ||
| Q4 24 | $-1.13 | — | ||
| Q3 24 | $-1.47 | — | ||
| Q2 24 | — | $0.81 | ||
| Q2 23 | — | $0.99 | ||
| Q2 22 | — | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.2M | $41.6M |
| 总债务越低越好 | $55.0M | — |
| 股东权益账面价值 | $-239.5M | $-129.4M |
| 总资产 | $327.5M | $210.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BLLNGDEV
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | $41.6M | ||
| Q4 24 | $191.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $50.8M | ||
| Q2 23 | — | $68.6M | ||
| Q2 22 | — | $91.4M |
总债务BLLNGDEV
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
股东权益BLLNGDEV
| Q3 25 | $-239.5M | — | ||
| Q2 25 | — | $-129.4M | ||
| Q4 24 | $-251.7M | — | ||
| Q3 24 | $-242.9M | — | ||
| Q2 24 | — | $-118.7M | ||
| Q2 23 | — | $-135.8M | ||
| Q2 22 | — | $-105.2M |
总资产BLLNGDEV
| Q3 25 | $327.5M | — | ||
| Q2 25 | — | $210.2M | ||
| Q4 24 | $302.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $282.8M | ||
| Q2 23 | — | $302.2M | ||
| Q2 22 | — | $373.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | — |
| 自由现金流经营现金流 - 资本支出 | $6.5M | — |
| 自由现金流率自由现金流/营收 | 7.7% | — |
| 资本支出强度资本支出/营收 | 8.8% | — |
| 现金转化率经营现金流/净利润 | 2.42× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BLLNGDEV
| Q3 25 | $13.8M | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | $21.1M |
自由现金流BLLNGDEV
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
自由现金流率BLLNGDEV
| Q3 25 | 7.7% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
资本支出强度BLLNGDEV
| Q3 25 | 8.8% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
现金转化率BLLNGDEV
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | 0.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
GDEV
暂无分部数据
